Eclipse Treatment Planning System (v18.0)
System, Planning, Radiation Therapy Treatment. 510(k) K230557, from Varian Medical Systems, Inc. (Palo Alto, CA). Product code MUJ, class 2.
As of Nov 19, 2026, K230557 is an FDA 510(k) held by Varian Medical Systems, Inc., substantially equivalent on May 26, 2023 after 87 days, with no recalls tied to it in FDA's recall database.
- Review time: 87 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The Eclipse Treatment Planning System (Eclipse TPS) is used to plan radiotherapy treatments for patients with malignant or benign diseases. Eclipse TPS is used to plan external beam irradiation with photon, electron and proton beams, as well as for internal radiation (brachytherapy) treatments.
- Eclipse Treatment Planning System v16.1K201607 · Varian Medical Systems, Inc. · Jul 10, 2020
- PlanOne 1K250963 · Cosylab Jsc, Control System Laboratory · Nov 20, 2025
- Eclipse Treatment Planning System (18.1)K242378 · Varian Medical Systems · Dec 11, 2024
- RT Elements (4.6)K261655 · Brainlab SE · Oct 5, 2026
- Virtual Cone (1.0)K260750 · Varian Medical Systems, Inc. · Jul 8, 2026
- RadOncAIK253050 · Informai · Jun 18, 2026
- Multimodality Simulation Workspace (MM Sim) (v1.0.0)K260207 · Philips Medical Systems Nederland B.V. · May 27, 2026
- eXaSkin PlusK252784 · Anatomical Geometry S.L. · May 22, 2026
- ART.1-USK253078 · Seetreat Pty, Ltd. · May 14, 2026
- syngo.via RT Image Suite VC10K252304 · Varian Medical Systems, Inc. · Mar 18, 2026
- Monaco RTP System (6.3)K252002 · Elekta Solutions AB · Feb 19, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 28, 2023
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files